In vivo efficacy and safety of skin electroporation

Advanced Drug Delivery Reviews

Volumn 35, Issue 1, 1999, Pages 77-88

  Vanbever, Rita ^a   Préat, Véronique ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Electroporation; Iontophoresis; Skin; Topical drug delivery; Transdermal drug delivery

Indexed keywords

BIOELECTRIC PHENOMENA; MECHANICAL PERMEABILITY; SKIN; TRANSPORT PROPERTIES;

ELECTROPORATION; IONTOPHORESIS;

CONTROLLED DRUG DELIVERY;

ANTISENSE OLIGONUCLEOTIDE; CALCEIN; CYCLOSPORIN A; FENTANYL; FLURBIPROFEN; GONADORELIN;

CELL MEMBRANE CONDUCTANCE; DRUG BLOOD LEVEL; ELECTRODE; ELECTROPORATION; HISTOLOGY; HUMAN; IN VITRO STUDY; INTERMETHOD COMPARISON; IONTOPHORESIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SAFETY; SKIN PERMEABILITY; STRATUM CORNEUM; TECHNIQUE; TISSUE INJURY; TOPICAL DRUG ADMINISTRATION; TRANSDERMAL DRUG ADMINISTRATION;

EID: 0345434850     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(98)00064-7     Document Type: Article

References (51)

1. J. Hadgraft, R.H. Guy (Eds.), Transdermal Drug Delivery - Development Issues and Research Initiatives, Marcel Dekker, New York, 1989.
2. E.W. Smith, H.I. Maibach, Percutaneous Penetration Enhancers, CRC Press, Boca Raton, FL, 1995.
3. Abidor I.G., Arakelyan V.B., Chernomordik L.V., Chizmadzhev Y.A., Pastushenko V.F., Tarasevich M.R. Electric breakdown of bilayer membranes: I. The main experimental facts and their qualitative discussion. Bioelectrochem. Bioenerg. 6:1979;37-52.
4. E. Neuman, A.E. Sowers, C.A. Jordan (Eds.), Electroporation and Electrofusion in Cell Biology, Plenum, New York, 1989.
5. D.C. Chang, B.M. Chassy, J.A. Saunders, A. Sowers (Eds.), Guide to Electroporation and Electrofusion, Academic Press, New York, 1992.
6. J.C. Weaver, Electroporation theory: concepts and mechanisms, in: J.A. Nickoloff (Ed.), Molecular Biology, Methods (1995) 3-28.
7. J.C. Weaver, Y.A. Chizmadzhev, Electroporation, in: C. Polk, E. Postow (Eds.), Handbook of Biological Effects of Electromagnetic Fields, CRC Press, Boca Raton, FL, 1996, pp. 247-274.
8. Prausnitz M.R., Bose V.G., Langer R., Weaver J.C. Electroporation of mammalian skin: A mechanism to enhance transdermal drug delivery. Proc. Natl. Acad. Sci. USA. 90:1993;10504-10508.
9. Vanbever R., Lecouturier N., Préat V. Transdermal delivery of metoprolol by electroporation. Pharm. Res. 11:1994;1657-1662.
10. Bommannan D., Tamada J., Leung L., Potts R.O. Effect of electroporation on transdermal iontophoretic delivery of luteinizing hormone releasing hormone (LHRH) in vitro. Pharm. Res. 11:1994;1809-1814.
11. Pliquett U., Weaver J.C. Electroporation of human skin: simultaneous measurement of changes in the transport of two fluorescent molecules and in the passive electrical properties. Bioelectrochem. Bioenerg. 39:1996;1-12.
12. Vanbever R., Langers G., Montmayeur S., Préat V. Transdermal delivery of fentanyl: rapid onset of analgesia using skin electroporation. J. Control. Release. 50:1998;225-235.
13. Vanbever R., Fouchard D., Jadoul A., De Morre N., Préat V., Marty J.-P. In vivo non-invasive evaluation of hairless rat skin after high-voltage pulse exposure. Skin Pharmacol. Appl. Skin Physiol. 11:1998;23-34.
14. Prausnitz M.R. A practical assessment of transdermal drug delivery by skin electroporation. Adv. Drug Deliv. Rev. 35:1999;61-76.
15. Singh P., Maibach H.I. Iontophoresis: an alternative to the use of carriers in cutaneous delivery. Adv. Drug. Deliv. Rev. 18:1996;379-394.
16. Zewert T.E., Pliquett U.F., Langer R.S., Weaver J.C. Transdermal transport of DNA antisense oligonucleotides by electroporation. Biochem. Biophys. Acta. 212:1995;286-292.
17. Prausnitz M.R., Edelman E.R., Gimm J.A., Langer R., Weaver J.C. Transdermal delivery of heparin by skin electroporation. Biotechnology. 13:1995;1205-1209.
18. Vanbever R., Le Boulengé E., Préat V. Transdermal delivery of fentanyl by electroporation. I. Influence of electrical factors. Pharm. Res. 13:1996;559-565.
19. Vanbever R., De Morre N., Préat V. Transdermal delivery of fentanyl by electroporation. II. Mechanisms involved in drug transport. Pharm. Res. 13:1996;1359-1365.
20. Jadoul A., Préat V. Electrically-enhanced transdermal delivery of domperidone. Int. J. Pharm. 154:1997;229-234.
21. Jadoul A., Lecouturier N., Mesens J., Caers W., Préat V. Electrically enhanced transdermal delivery of alnitidan. J. Control. Release. 54:1998;265-272.
22. Vanbever R., Leroy M.-A., Préat V. Transdermal permeation of neutral molecules by electroporation. J. Control. Release. 54:1998;243-250.
23. Regnier V., Le Doan T., Préat V. Topical delivery of phosphorothioate oligonucleotides to the skin by electroporation. J. Drug Target. 5:1998;275-289.
24. U. Pliquett, M.R. Prausnitz, Y.A. Chizmadzhev, J.C. Weaver, Measurement of rapid release kinetics for drug delivery, Pharm. Res. 12 (1995) 549-555 (Errata in Pharm. Res. 12 (1995) 1244).
25. U. Pliquett, M.R. Prausnitz, Y.A. Chizmadzhev, J.C. Weaver, Measurement of rapid release kinetics for drug delivery, Pharm. Res. 12 (1995) 549-555 (Errata in Pharm. Res. 12 (1995) 1244).
26. Prausnitz M.R., Pliquett U., Langer R., Weaver J.C. Rapid temporal control of transdermal drug delivery by electroporation. Pharm. Res. 11:1994;1834-1837.
27. Prausnitz M.R., Seddick D.S., Kon A.A., Bose V.G., Frankenburg S., Klaus S.N., Langer R., Weaver J.C. Methods for in vivo tissue electroporation using surface electrodes. Drug Deliv. 1:1993;125-131.
28. Varvel J.R., Shafer S.L., Hwang S.S., Coen P.a., Stanski D.R. Absorption characteristics of transdermally administered fentanyl. Anesthesiology. 70:1989;928-934.
29. Perez de la Cruz M., Eeckhoudt S., Verbeeck R., Préat V. Transdermal delivery of flurbiprofen in the rat by iontophoresis and electroporation. Pharm. Res. 11(S14):1997;309.
30. Hofmann G.A., Rustrum W.V., Suder K.S. Electro-incorporation of microcarriers as a method for the transdermal delivery of large molecules. Bioelectrochem. Bioenerg. 38:1995;209-222.
31. Prausnitz M.R., Lee C.S., Liu C.H., Pang J.C., Singh T.P., Langer R.S., Weaver J.C. Transdermal transport efficiency during skin electroporation and iontophoresis. J. Control. Release. 38:1996;205-217.
32. Pliquett U., Langer R., Weaver J.C. Changes in the passive electrical properties of human stratum corneum due to electroporation. Biochim. Biophys. Acta. 1239:1995;111-121.
33. Prausnitz M.R., Gimm J.A., Guy R.H., Langer R.S., Weaver J.C., Cullander C. Imaging of transport pathways across human stratum corneum during high-voltage and low-voltage exposures. J. Pharm. Sci. 85:1996;1363-1370.
34. Pliquett U.F., Zewert T.E., Chen T., Langer R.S., Weaver J.C. Imaging of fluorescent molecule and small ion transport through human stratum corneum during high-voltage pulsing: localized transport regions are involved. Biophys. Chem. 58:1996;185-204.
35. Riviere J.E., Monteiro-Riviere N.A., Rogers R.A., Bommannan D., Tamada J.A., Potts R.O. Pulsatile transdermal delivery of LHRH using electroporation: drug delivery and skin toxicology. J. Control. Release. 36:1995;229-233.
36. Prausnitz M.R. Do high-voltage pulses cause changes in skin structure? J. Control. Release. 40:1996;321-326.
37. Mir L., Orlowski S., Belehradek J.J., Paolelli C. Electrochemotherapy: potentiation of antitumor effect of bleomycin by electric pulses. Eur. J. Cancer. 27:1991;68-72.
38. Belahradek N., Domenge Ch., Luboinski B., Orlowski S., Belehradek J., Mir L. Electrochemotherapy: a new antitumor treatment. First clinical phase I-III Trials. Cancer. 72:1993;3694-3700.
39. Heller R., Jaroszeski R., Glass L.F., Messina J., Rappaport D., De Conti R., Fenske N., Gilbert B., Mir L., Reintgen D. Phase I/II Trial for the treatment of cutaneous and subcutaneous tumor using electrochemotherapy. Cancer. 77:1996;964-971.
40. Mir L.M., Orlowski Mechanisms of electrochemotherapy S. Adv. Drug Deliv. Rev. 35:1999;107-118.
41. Titomirov A., Sukharev S., Kistanova E. In vivo electroporation and stable transformation of skin cells of newborn mice by plasmid DNA. Biochim. Biophys. Acta. 1088:1991;131-134.
42. Zhang L., Li L., Hofmann G.A., Hoffman R.M. Depth-targeted efficient gene delivery and expression in the skin by pulsed electric fields: an approach to gene therapy of skin aging and other diseases. Biochem. Biophys. Res. Commun. 220:1996;633-636.
43. Zhang L., Li L.N., An Z.L., M Hoffman R., Hofmann G.A. In vivo transdermal delivery of large molecules by pressure-mediated electroincorporation and electroporation: a novel method for drug and gene delivery. Bioelectrochem. Bioenerg. 42:1997;283-292.
44. Wang S., Kara M., Krisnan T.R. Topical delivery of cyclosporin A coevaporate using electroporation technique. Drug Dev. Ind. Pharm. 23(7):1997;657-670.
45. V. Regnier, V. Préat, Localisation of a FITC-labelled phosphorothioate oligodeoxynucleotide in the skin after topical delivery by iontophoresis or electroporation, Pharm. Res. 15 (1998) no. 10.
46. Jadoul A., Regnier V., Doucet J., Durand D., Préat V. X-ray scattering analysis of the stratum corneum treated by high voltage pulses. Pharm. Res. 14:1997;1275-1277.
47. Jadoul A., Tanajo H., Préat V., Spies F., Boddé H. Electroperturbation of human stratum corneum fine structure by high voltage pulses: A freeze fracture electron microscopy and differential thermal analysis study. J. Invest. Dermatol. Symp. Proc. 3:1998;153-158.
48. Jadoul A., Bouwstra J., Préat V. Repercussions of iontophoresis and electroporation on the stratum corneum integrity: review of biophysical studies. Adv. Drug Deliv. Rev. 35:1999;89-105.
49. Ledger P.W. Skin biological issues in electrically enhanced transdermal delivery. Adv. Drug Deliv. Rev. 9:1992;289-307.
50. Prausnitz M.R. The effects of electric current applied to the skin: a review for transdermal drug delivery. Adv. Drug Deliv. Rev. 18:1996;395-425.
51. J.C. Weaver, personal communication (1997).